Monoclonal gammopathy of undetermined significance primary prevention: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Okamal (talk | contribs)
nocaptcha
1,371 edits
No edit summary
Okamal (talk | contribs)
nocaptcha
1,371 edits
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{ Monoclonal gammopathy of undetermined significance }}
{{Monoclonal gammopathy of undetermined significance }}
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}  


==Overview==
==Overview==
There are no established measures for the primary prevention of [disease name].
There are no established measures for the primary prevention of [[MGUS]]
 
OR
 
There are no available vaccines against [disease name].
 
OR
 
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
 
OR
 
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].


==Primary Prevention==
==Primary Prevention==
There are no established measures for the primary prevention of [disease name].
There are no established measures for the primary prevention of [[MGUS]].
 
OR
 
There are no available vaccines against [disease name].
 
OR
 
Effective measures for the primary prevention of [disease name] include:
*[Measure1]
*[Measure2]
*[Measure3]
 
OR
 
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
*[Strategy 1]
*[Strategy 2]
*[Strategy 3]


==References==
==References==
Line 44: Line 14:
{{WH}}
{{WH}}
{{WS}}
{{WS}}


[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Disease]]
[[Category:Disease]]

Revision as of 17:23, 14 August 2018

Monoclonal gammopathy of undetermined significance Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Monoclonal gammopathy of undetermined significance from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Monoclonal gammopathy of undetermined significance primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Monoclonal gammopathy of undetermined significance primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Monoclonal gammopathy of undetermined significance primary prevention

on Monoclonal gammopathy of undetermined significance primary prevention

Monoclonal gammopathy of undetermined significance primary prevention in the news

Blogs on Monoclonal gammopathy of undetermined significance primary prevention

Directions to Hospitals Treating Monoclonal gammopathy of undetermined significance

Risk calculators and risk factors for Monoclonal gammopathy of undetermined significance primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established measures for the primary prevention of MGUS

Primary Prevention

There are no established measures for the primary prevention of MGUS.

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Monoclonal_gammopathy_of_undetermined_significance_primary_prevention&oldid=1490422"